FSL-1, a bacterial-derived toll-like receptor 2/6 agonist, enhances resistance to experimental HSV-2 infection

BACKGROUND: Herpes simplex virus type 2 (HSV-2) is a leading cause of genital ulceration that can predispose individuals to an increased risk of acquiring other sexually transmitted infections. There are no approved HSV-2 vaccines and current suppressive therapies require daily compound administrati...

Descripción completa

Detalles Bibliográficos
Autores principales: Rose, William A, McGowin, Chris L, Pyles, Richard B
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2009
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2780411/
https://www.ncbi.nlm.nih.gov/pubmed/19903337
http://dx.doi.org/10.1186/1743-422X-6-195

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2780411/
https://www.ncbi.nlm.nih.gov/pubmed/19903337
http://dx.doi.org/10.1186/1743-422X-6-195

Ejemplares similares